Most Read This Week
- Real-World Use Patterns, Effectiveness, and Tolerability of Sacituzumab Govitecan for the Second-Line and Later-Line Treatment of Metastatic TNBC in the US
- Risk of Second Tumors and T-Cell Lymphoma After CAR T-Cell Therapy
- Adjuvant Trastuzumab Emtansine vs Paclitaxel Plus Trastuzumab for Stage I HER2-Positive Breast Cancer
- Perioperative Nivolumab vs Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy
- Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer
Recently Updated
- Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
- Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle Cell
- Nudge in EHR Can Reduce Unnecessary Sentinel Lymph Node Biopsy
- Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer
- Disparities Persist in Postmastectomy Reconstruction